Cargando…

Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling

Genome‐scale metabolic models (GEMs) have proven useful as scaffolds for the integration of omics data for understanding the genotype–phenotype relationship in a mechanistic manner. Here, we evaluated the presence/absence of proteins encoded by 15,841 genes in 27 hepatocellular carcinoma (HCC) patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agren, Rasmus, Mardinoglu, Adil, Asplund, Anna, Kampf, Caroline, Uhlen, Mathias, Nielsen, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Molecular Biology Organization 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017677/ https://www.ncbi.nlm.nih.gov/pubmed/24646661 http://dx.doi.org/10.1002/msb.145122

Ejemplares similares

Integration of clinical data with a genome-scale metabolic model of the human adipocyte
por: Mardinoglu, Adil, et al.
Publicado: (2013)

Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Metabolic Network-Based Identification and Prioritization of Anticancer Targets Based on Expression Data in Hepatocellular Carcinoma
por: Bidkhori, Gholamreza, et al.
Publicado: (2018)

Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
por: Larsson, Ida, et al.
Publicado: (2020)

Revealing the Metabolic Alterations during Biofilm Development of Burkholderia cenocepacia Based on Genome-Scale Metabolic Modeling
por: Altay, Ozlem, et al.
Publicado: (2021)

Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT
por: Agren, Rasmus, et al.
Publicado: (2012)

New Challenges to Study Heterogeneity in Cancer Redox Metabolism
por: Benfeitas, Rui, et al.
Publicado: (2017)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Systems biology perspective for studying the gut microbiota in human physiology and liver diseases
por: Altay, Ozlem, et al.
Publicado: (2019)

Predicting growth of the healthy infant using a genome scale metabolic model
por: Nilsson, Avlant, et al.
Publicado: (2017)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
por: Proffitt, Ceri, et al.
Publicado: (2022)

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma
por: Yuan, Meng, et al.
Publicado: (2022)

Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
por: Rosario, Dorines, et al.
Publicado: (2018)

Sampling the Solution Space in Genome-Scale Metabolic Networks Reveals Transcriptional Regulation in Key Enzymes
por: Bordel, Sergio, et al.
Publicado: (2010)

Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis
por: Lee, Sunjae, et al.
Publicado: (2016)

Transcriptomics resources of human tissues and organs
por: Uhlén, Mathias, et al.
Publicado: (2016)

MEMOSys: Bioinformatics platform for genome-scale metabolic models
por: Pabinger, Stephan, et al.
Publicado: (2011)

The Potential Use of Metabolic Cofactors in Treatment of NAFLD
por: Mardinoglu, Adil, et al.
Publicado: (2019)

Personal model‐assisted identification of NAD(+) and glutathione metabolism as intervention target in NAFLD
por: Mardinoglu, Adil, et al.
Publicado: (2017)

Cancer Metabolism: A Modeling Perspective
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Genome-scale metabolic reconstructions of Pichia stipitis and Pichia pastoris and in silico evaluation of their potentials
por: Caspeta, Luis, et al.
Publicado: (2012)

ESS: A Tool for Genome-Scale Quantification of Essentiality Score for Reaction/Genes in Constraint-Based Modeling
por: Zhang, Cheng, et al.
Publicado: (2018)

Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
por: Benfeitas, Rui, et al.
Publicado: (2018)

Informing Pharmacokinetic Models With Physiological Data: Oral Population Modeling of L-Serine in Humans
por: Bosley, J. R., et al.
Publicado: (2021)

The RAVEN Toolbox and Its Use for Generating a Genome-scale Metabolic Model for Penicillium chrysogenum
por: Agren, Rasmus, et al.
Publicado: (2013)

Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases
por: Lam, Simon, et al.
Publicado: (2022)

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
por: Li, Xiangyu, et al.
Publicado: (2021)

Addressing the heterogeneity in liver diseases using biological networks
por: Lam, Simon, et al.
Publicado: (2020)

A tool to facilitate clinical biomarker studies - a tissue dictionary based on the Human Protein Atlas
por: Kampf, Caroline, et al.
Publicado: (2012)

Adaptive Evolution of Phosphorus Metabolism in Prochlorococcus
por: Casey, John R., et al.
Publicado: (2016)

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
por: Li, Xiangyu, et al.
Publicado: (2022)

Editorial: The Impact of Systems Medicine on Human Health and Disease
por: Mardinoglu, Adil, et al.
Publicado: (2016)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling
por: Lindskog, Cecilia, et al.
Publicado: (2015)

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease
por: Yang, Hong, et al.
Publicado: (2021)

Understanding the interactions between bacteria in the human gut through metabolic modeling
por: Shoaie, Saeed, et al.
Publicado: (2013)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m9a9d6r3b9ekgl0tqoqq2qqn15